Prostate cancer screening and the associated controversy
W Tabayoyong, R Abouassaly - Surgical Clinics, 2015 - surgical.theclinics.com
Prostate cancer is the most common cancer diagnosed in males in the United States. In
2014, the American Cancer Society estimated that 233,000 patients would be diagnosed …
2014, the American Cancer Society estimated that 233,000 patients would be diagnosed …
Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer
Purpose To assess long-term outcomes of men with favorable-risk prostate cancer in a
prospective, active-surveillance program. Methods Curative intervention was recommended …
prospective, active-surveillance program. Methods Curative intervention was recommended …
Prostate‐specific antigen‐based prostate cancer screening: past and future
AR Alberts, IG Schoots… - International Journal of …, 2015 - Wiley Online Library
Prostate‐specific antigen‐based prostate cancer screening remains a controversial topic.
Up to now, there is worldwide consensus on the statement that the harms of population …
Up to now, there is worldwide consensus on the statement that the harms of population …
Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer
T Nordström, O Akre, M Aly, H Grönberg… - Prostate cancer and …, 2018 - nature.com
Background Screening for prostate cancer using prostate-specific antigen (PSA) alone leads
to un-necessary biopsying and overdiagnosis. PSA density is easily accessible, but early …
to un-necessary biopsying and overdiagnosis. PSA density is easily accessible, but early …
Clinical utility of quantitative Gleason grading in prostate biopsies and prostatectomy specimens
G Sauter, S Steurer, TS Clauditz, T Krech, C Wittmer… - European urology, 2016 - Elsevier
Background Gleason grading is the strongest prognostic parameter in prostate cancer.
Gleason grading is categorized as Gleason≤ 6, 3+ 4, 4+ 3, 8, and 9–10, but there is …
Gleason grading is categorized as Gleason≤ 6, 3+ 4, 4+ 3, 8, and 9–10, but there is …
Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
There is considerable variability among men's values and preferences regarding prostate
cancer screening. Men who place a high value in avoiding complications from biopsies and …
cancer screening. Men who place a high value in avoiding complications from biopsies and …
Comparison between the four-kallikrein panel and prostate health index for predicting prostate cancer
Background The four-kallikrein panel and the Prostate Health Index (PHI) have been shown
to improve prediction of prostate cancer (PCa) compared with prostate-specific antigen …
to improve prediction of prostate cancer (PCa) compared with prostate-specific antigen …
[HTML][HTML] Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
Standard clinicopathological variables are inadequate for optimal management of prostate
cancer patients. While genomic classifiers have improved patient risk classification, the …
cancer patients. While genomic classifiers have improved patient risk classification, the …
Risk score predicts high‐grade prostate cancer in DNA‐methylation positive, histopathologically negative biopsies
BACKGROUND Prostate cancer (PCa) diagnosis is challenging because efforts for effective,
timely treatment of men with significant cancer typically result in over‐diagnosis and repeat …
timely treatment of men with significant cancer typically result in over‐diagnosis and repeat …
Economic analysis of prostate-specific antigen screening and selective treatment strategies
Importance Prostate-specific antigen (PSA) screening for prostate cancer is controversial.
Experts have suggested more personalized or more conservative strategies to improve …
Experts have suggested more personalized or more conservative strategies to improve …